Ovarian cancer Clinical Trials in Kenosha, WI
As of June 2026, 2 paid clinical trials are recruiting for Ovarian cancer in Kenosha, Wisconsin. Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Kenosha
Filter results
2 clinical trials for Ovarian cancer
·Clear filters·↓ Download CSVA Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
About research studies in Kenosha
Kenosha has approximately 65 recruiting research studies across a wide range of therapeutic areas. Wisconsin hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Kenosha
Researchers run research studies in Kenosha, WI at 14 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Aurora Cancer Care-Kenosha South | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 51 |
| Aurora Medical Center Kenosha | Infant and Young Child Feeding, Lumbar Spinal Stenosis | 2 |
| Aurora Cancer Care - Kenosha South | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Clinical Investigation Specialists | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Clinical Investigation Specialists, Inc | Pediatric Migraine | 1 |
| Clinical Investigation Specialists, Inc.-Kenosha-69111 | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Elios Vision Clinical Site | Glaucoma, Primary Open Angle | 1 |
| Eye Centers Of Racine And Kenosha | Primary Open Angle Glaucoma | 1 |
| Glaukos Investigative Site | Ocular Hypertension (OH), Open Angle Glaucoma (OAG) | 1 |
| Glaukos Investigator Site | Glaucoma, Open-angle, Ocular Hypertension (OHT), Phacoemulsification Cataract Surgery | 1 |
| The Eye Centers of Racine & Kenosha | Open Angle Glaucoma (OAG) | 1 |
| The Eye Centers of Racine and Kenosha, LTD | Blepharoplasty | 1 |
| Vivent Health Clinic | HIV Infections, Substance Use Disorders | 1 |
Active & Upcoming Studies in Kenosha (2026)
Recruiting trials in Kenosha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (48 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
Eye & vision (5 active studies)
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg · Glaukos Corporation
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma · Avisi Technologies Inc.
Cardiovascular (4 active studies)
- Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg · Glaukos Corporation
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Pediatric (2 active studies)
- Standardized Application of Feeding Evaluations Using SMART Tool · Wake Forest University Health Sciences
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
HIV / STI (1 active study)
- Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders · University of Wisconsin, Madison
Mental health & behavior (1 active study)
- Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders · University of Wisconsin, Madison
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Kenosha
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Stage IV Lung Cancer AJCC v8 (4 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Advanced Lung Non-Small Cell Carcinoma (3 active studies). Recruiting Advanced Lung Non-Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage I Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage III Breast Cancer AJCC v8 (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Lung Non-Small Cell Carcinoma (3 active studies). Recruiting Lung Non-Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Kenosha
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Wisconsin are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Wisconsin research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Kenosha. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Kenosha
Hipa.ai aggregates every recruiting study in Kenosha from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Kenosha?
There are approximately 65 recruiting clinical trials in Kenosha, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Kenosha pay participants?
Most recruiting trials in Kenosha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Kenosha?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Kenosha?
The most common conditions under active study in Kenosha include Anatomic Stage II Breast Cancer AJCC v8 (4), Stage IV Lung Cancer AJCC v8 (4), Advanced Lung Non-Small Cell Carcinoma (3), Anatomic Stage I Breast Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Kenosha?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kenosha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Kenosha?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Kenosha?
Recruiting research sites in Kenosha include Aurora Cancer Care-Kenosha South, Aurora Medical Center Kenosha, Aurora Cancer Care - Kenosha South, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Kenosha right now?
The largest active categories in Kenosha are Cancer & tumors (48), Eye & vision (5), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.